Mineralys Therapeutics In... (MLYS)
NASDAQ: MLYS
· Real-Time Price · USD
39.65
1.14 (2.96%)
At close: Sep 26, 2025, 3:28 PM
Mineralys Therapeutics Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for MLYS stock have an median target of 46.5, with a low estimate of 42 and a high estimate of 52. The median target predicts an increase of 17.28% from the current stock price of 39.65.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 42 | 46.75 | 46.5 | 52 |
| Change | 5.93% | 17.91% | 17.28% | 31.15% |
Latest Analyst Insight Report
HC Wainwright reiterates Buy (PT $42). Lorundrosta... Unlock content with Pro Subscription
Updated Sep 08, 2025
| Rating | Mar 25 | Apr 25 | May 25 | Jun 25 | Aug 25 | Sep 25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 0 | 0 | 1 | 1 |
| Buy | 1 | 0 | 1 | 1 | 1 | 2 |
| Hold | 0 | 0 | 0 | 1 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 2 | 2 | 4 |
Financial Forecast this Year
Revenue This Year
n/a
Revenue Next Year
11.28M
from 0
Increased by n/a%
EPS This Year
-2.72
from -3.66
Increased by 25.7%
EPS Next Year
-2.65
from -2.72
Increased by 2.6%